
FDA calls for healthcare worker feedback to enhance monitoring of AI-enabled medical devices in real-world settings.
Key Details
- 1FDA opens comment window (Sept 30–Dec 1) for real-world monitoring of AI-equipped devices.
- 2Agency seeks input on detection and mitigation of data/model drift and performance changes.
- 3Most current evaluations rely on static retrospective testing, which FDA says is insufficient.
- 4End-users with experience of deployed AI tools are specifically invited to contribute insights.
- 5Recent breakthroughs: FDA Breakthrough Device status for Aidoc's AI triage solution; new AI approaches to body composition assessment (Mass General Brigham), and mammogram-based CVD risk prediction.
Why It Matters
Robust post-market monitoring and ongoing user feedback are vital as more AI tools are deployed in radiology and medical imaging. These regulatory efforts shape safe, effective, and continually improving AI integration in clinical practice.

Source
AI in Healthcare
Related News

•AuntMinnie
SIIM-CAIMI Showcases Advances and Future Trends in Radiology AI
SIIM-CAIMI 2024 explored the future of radiology AI, emphasizing multidisciplinary collaboration and novel research.

•AuntMinnie
DeepHealth AI Suite Expands Radiology Insights Across Modalities
DeepHealth's Radiology AI Suite enables radiologists to detect more findings and extract additional risk and disease progression information from a wide range of imaging exams.

•Radiology Business
Weill Cornell Investigates Unauthorized Use of Radiology Data in AI Research
Weill Cornell Medicine reported improper use of patient information in radiology AI research, violating privacy protocols.